Simple blood or urine test could spot kidney cancer early
NCT ID NCT06339138
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study collects blood, tissue, and urine from about 589 people with different types of kidney or urinary tract tumors, plus healthy volunteers. Researchers are looking for special DNA markers (methylated DNA) that could help detect these cancers earlier and more accurately. The goal is to develop a simple, non-invasive test using blood or urine samples.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHROMOPHOBE RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Pronged immune attack shrink kidney tumors before surgery?
- Can a new nucleotide analogue boost cancer treatment?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can a tracer that hunts unstable iron light up hidden tumors?
- Can a Two-Drug attack shrink Hard-to-Treat bladder tumors?
- Can a pill that starves tumors of oxygen help fight advanced cancer?